Sections
Log in
Top News
U.S. News World News Featured Voices
Odd News
Entertainment
Movies Music TV
Sports
Soccer NFL NBA MLB
Photos
News Entertainment Sports Features
More...
Defense Featured Science Health Video Archive Almanac
About Feedback Privacy Policy
About Feedback Privacy Policy
Search
Health News
Aug. 11, 2016 / 10:58 AM

Anti-inflammatory drug shows promise for Alzheimer's disease treatment

Mefenamic acid reversed memory problems in mice, suggesting the NSAID could do the same for humans, say researchers.

By
Stephen Feller
The NSAID mefenamic acid, used to help control menstrual pain, may also have an effect on reversing memory problems linked to Alzheimer's disease, researchers report in a recent study. Photo by University of Manchester
The NSAID mefenamic acid, used to help control menstrual pain, may also have an effect on reversing memory problems linked to Alzheimer's disease, researchers report in a recent study. Photo by University of Manchester

MANCHESTER, England, Aug. 11 (UPI) -- A common anti-inflammatory drug reversed memory problems similar to Alzheimer's disease in mice, suggesting inflammation makes the disease worse and that treating inflammation may lessen its effects.

The non-steroidal anti-inflammatory drug mefenamic acid, marketed as Ponstel, helped fix memory problems in mice, according to researchers at the University of Manchester, though researchers say trials in humans are necessary.

Previous studies have shown brain inflammation contributes to the intensification of Alzheimer's disease, which researchers say makes it an obvious target for treatment.

Ponstel is a prescription NSAID used to control mild-to-severe pain, specifically pain and blood loss during menstruation. The drug targets an inflammatory pathway called NLRP3 inflammasome, which can damage brain cells -- which is why the researchers tested it in mice with Alzheimer's-like symptoms.

RELATED Study: Read more books, live a longer life

"Until now, no drug has been available to target this pathway, so we are very excited by this result," Dr. David Brough, a researchers at the University of Manchester, said in a press release. "However, much more work needs to be done until we can say with certainty that it will tackle the disease in humans as mouse models don't always faithfully replicate the human disease."

For the study, published in the journal Nature Communications, researchers treated two groups of 10 mice with Alzheimer's disease symptoms, giving one mefenamic acid through a miniature pump implanted under their skin for one month and the other a placebo delivered the same way.

Memory loss in mice treated with the drug had Alzheimer's symptoms reverse, seeing memory return to levels seen in mice without the disease.

RELATED Younger onset Alzheimer's poorly recognized in men, study says

While the drug showed potential, and already is used for treatment in humans, the researchers say further research will be needed to identify potential side effects in patients taking it for Alzheimer's, as well as establish whether it is effective.

"Because this drug is already available and the toxicity and pharmacokinetics of the drug is known, the time for it to reach patients should, in theory, be shorter than if we were developing completely new drugs," Brough said. "We are now preparing applications to perform early phase II trials to determine a proof-of-concept that the molecules have an effect on neuroinflammation in humans."

RELATED Computerized brain training delays dementia development, study says
  • Topics
  • Alzheimer's Disease
  • Phase II

Latest Headlines

Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Health News // 4 hours ago
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Dec. 16 (UPI) -- A new study in the American Journal of Preventive Medicine revealed that three-quarters of teens who vape use the e-cigarette devices to smoke not just nicotine products but marijuana as well.

'Prehab' before surgery helps speed seniors' recovery
Health News // 19 hours ago
'Prehab' before surgery helps speed seniors' recovery
"Training" for surgery can improve seniors' outcomes and reduce insurance costs, a new study says.

Indoor pollutants may raise allergy risk in toddlers
Health News // 19 hours ago
Indoor pollutants may raise allergy risk in toddlers
Toddlers have an increased risk of allergies if they are exposed to multiple indoor pollutants in their first years of life, a new study finds.

Premium changes, Medicaid expansion driving ACA enrollment drop
Health News // 2 days ago
Premium changes, Medicaid expansion driving ACA enrollment drop
Dec. 13 (UPI) -- Why have fewer Americans used the federal insurance exchange this year than in years past? Increased premiums for enrollees that receive subsidies, more states expanding Medicaid and expansion of non-ACA plans.

CDC: 1,300 Americans have died from flu so far this year
Health News // 2 days ago
CDC: 1,300 Americans have died from flu so far this year
Dec. 13 (UPI) -- More than 4,000 new cases of influenza were confirmed across the country this week as flu season shifts into high gear.

New study shakes up thinking on hormone replacement therapy
Health News // 2 days ago
New study shakes up thinking on hormone replacement therapy
The debate about postmenopausal hormone therapy and breast cancer risk may have turned muddier: A new study suggests that two different types of hormone therapy have opposite effects on women's long-term risk.

Liquid biopsy may predict breast cancer recurrence
Health News // 2 days ago
Liquid biopsy may predict breast cancer recurrence
Dec. 13 (UPI) -- A new tool could make it easier to predict whether early-stage triple-negative breast cancer will return following chemotherapy, according to results of a trial using a liquid biopsy to detect circulating tumor DNA.

Breast cancer drug found effective nearly six years after treatment
Health News // 3 days ago
Breast cancer drug found effective nearly six years after treatment
Dec. 13 -- Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50 percent less likely to have been struck by the disease, new research shows.

Study: Secondhand smoke increases heart disease risk in children
Health News // 3 days ago
Study: Secondhand smoke increases heart disease risk in children
Dec. 13 -- Secondhand smoke can harm children's arteries, a new study warns, finding that smoke caused increased stiffness in the abdominal aortas of kids in the study.

Kids whose parents are depressed have different brains
Health News // 3 days ago
Kids whose parents are depressed have different brains
The brains of kids who have a high risk of depression because they have parents with depression are structurally different from other kids' brains, a new study finds.

Trending Stories

'Prehab' before surgery helps speed seniors' recovery
'Prehab' before surgery helps speed seniors' recovery
Indoor pollutants may raise allergy risk in toddlers
Indoor pollutants may raise allergy risk in toddlers
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Three-quarters of U.S. teens who vape use nicotine, marijuana, or both
Sleepy nurses could affect patient care
Sleepy nurses could affect patient care
Liquid biopsy may predict breast cancer recurrence
Liquid biopsy may predict breast cancer recurrence

Photo Gallery

 
Moments from the Billboard Women in Music red carpet
Moments from the Billboard Women in Music red carpet

Latest News

House judiciary committee releases report detailing impeachment articles
Famous birthdays for Dec. 16: Billy Gibbons, Miranda Otto
On This Day: Battle of the Bulge begins
UPI Almanac for Monday, Dec. 16, 2019
Dozens injured as police, protesters clash in Beirut
 
Back to Article
/
Back to top
About UPI Contact Feedback Advertisements Submit News Tips
Copyright © 2019 United Press International, Inc. All Rights Reserved.
Terms of UsePrivacy Policy